Julie Johnson, PharmD

About

Biography

I serve as the director of the Clinical and Translational Science Institute (CTSI), where I am the Principal Investigator of a seven-year, $37.9 million Clinical and Translational Science Award from the National Institutes of Health. I am also an Associate Dean for Clinical and Translational Research in the Ohio State College of Medicine, Associate Vice President of Research for The Ohio State University, and hold the Dr. Samuel T. and Lois Felts Mercer Professorship of Pharmacology and Medicine.

Before joining Ohio State, I served on the faculty at the University of Florida (UF), where I was a Distinguished Professor of Pharmacy and Medicine and became the first female dean of the College of Pharmacy, serving from 2013 to 2022. Under my leadership, the University of Florida College of Pharmacy grew its faculty by 90% and rose from No. 14 to No. 5 in the U.S. News & World Report rankings of the best pharmacy colleges in the nation. The college’s annual research funding also increased from approximately No. 20 to No. 3 among the nation’s top colleges of pharmacy and achieved the highest percentage of underrepresented minority students among professional degree programs at UF. I also served as a department chair, Founding Director of the Center for Pharmacogenomics, and Founding Director of the UF Health Precision Medicine Program.

As an internationally recognized leader in clinical pharmacology, pharmacogenomics, and genomic medicine, I have an extensive record of clinical and translational research, focusing on cardiovascular pharmacogenomics and implementing precision medicine approaches into clinical practice. I have a long record of funding from the National Institutes of Health (NIH) and have secured approximately $55 million in research funding as a Principal Investigator. I have authored more than 330 peer-reviewed original research articles and was named a Clarivate Analytics Highly Cited Researcher—an accomplishment held by just 1 in 1,000 scientists globally whose publications rank in the top 1% of citations in the previous decade.

I also serve as the director of Ohio State’s Center for Clinical and Translational Science and am the Principal Investigator of a seven-year, $37.9 million Clinical and Translational Science Award from the NIH.

My research is focused on understanding genetic and other sources of variability in drug response, building evidence to support translation of research to clinical practice, implementing genomic medicine in practice and documenting clinical outcomes associated with use of genomic medicine in practice. My discovery research focuses primarily on cardiovascular drugs used in the treatment of hypertension and heart failure and used to prevent blood clots. My pharmacogenetics implementation work is across a range of therapeutic areas and explores clinical trial approaches for documenting its impact on clinical outcomes. I'm also deeply committed to training the next generation of clinical and translational scientists.

Credentials

Research

News and media

My news coverage

• NIH awards Ohio State $4.3 million grant to build clinical and translational scientist pipeline
• Ohio State appoints new leader of translational research, receives $37.9M NIH grant